Use of β-Agonists in inhalation injury

Journal of Burn Care and Research

Volumn 30, Issue 1, 2009, Pages 156-159

  Palmieri, Tina L ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; SALBUTAMOL;

ADULT RESPIRATORY DISTRESS SYNDROME; BURN; CLINICAL TRIAL; CONFERENCE PAPER; DRUG MECHANISM; HUMAN; PATIENT CARE; RESPIRATORY TRACT DISEASE;

EID: 59449083271     PISSN: 1559047X     EISSN: 15590488     Source Type: Journal    
DOI: 10.1097/BCR.0b013e3181923bc3     Document Type: Conference Paper

References (34)

1. Saffle JR, Davis B, Williams P. Recent outcomes in the treatment of burn injury in the United States: a report from the American Burn Association Patient Registry. J Burn Care Rehabil 1995;16:219-32.
2. Carvajal HF, Linares HA, Brouhard BH. Relationship of burn size to vascular permeability changes in rates. Surg Gynecol Obstet 1979;149:193-202.
3. Harms BA, Bodai BI, Kramer GC, Demling RH. Microvascular fluid and protein flux in pulmonary and systemic circulations after thermal injury. Microvasc Res 1982;23:77-86.
4. Ward PA, Till GO. Pathophysiologic events related to thermal injury of skin. J Trauma 1990;30:S75-S79.
5. Smith DL, Cairns BA, Ramadan F, et al. Effect of inhalation injury, burn size, and age on mortality: a study of 1447 consecutive burn patients. J Trauma 1994;37:655-9.
6. Wyncoll DL, Evans TW. Acute respiratory distress syndrome. Lancet 1999;354:497-501.
7. Frielle T, Daniel KW, Caron MG, Lefkowitz RJ. Structural basis of β-adrenergic receptor subtype specificity studies with chimeric β2/β2-adrenergic receptors. Proc Natl Acad Sci USA 1988;85:9494-8.
8. Henderson R, Baldwin JM, Ceska A, Zemlin F, Beckmann E, Downing KH. Model for the structure of bacteriorhodopsin based on high-resolution electron cryo-microscopv. J Mol Biol 1990;213:899-929.
9. 2-adrenergic receptor: a protein with multiple spanning domains and encoded by a gene whose chromosomal location is shared with that of a receptor for platelet growth factor. Proc Natl Acad Sci 1987;84:46-50.
10. Johnson M. Mechanisms of action of β-adrenoreceptor agonists. In: Costello JF, Mann RD, editors. Beta-agonists in the treatment of asthma. Carnforth: Parthenon; 1992. p. 27-42.
11. Spina D, Rigby RJ, Paterson JW, Goldie RG. Autoradiographic localization of β-adrenoreceptors in asthmatic human lung. Am Rev Respir Dis 1989;140:1410-5.
12. Hoffman EA, Chiplunkar R, Casale TB. CT scanning confirms beta receptor distribution is greater for small versus large airways. Am J Respir Crit Care Med 1997;155:A855.
13. Uekj J, Rhodes CG, Hughes JMB, et al. In vivo quantification of pulmonary β-adrenoreceptor density in humans with (S)-11C-CGP12177 and PET. J Appl Phvsiol 1993;75: 559-65.
14. Buckner CK, Abel P. Studies on the effects of the enantiomers of soterenol, trimtopuinol and salbutamol on β-adrenergic receptors of isolated guinea pig atria and trachea. J Pharm Exp Ther 1974;189:616-25.
15. Atabai K, Ward LB, Snider MD, et al. Aerosolized beta(2)-adrenergic agonists achieve therapeutic levels in the pulmonary edema fluid of ventilated patients with acute respiratory failure. Intensive Care Med 2002;28:705-11.
16. Morina P, Herrera M, Venegas J, Mora D, Rodríguez M, Pino E. Effects of nebulized salbutamol in respiratory me chanics in adult respiratory distress syndrome. Intensive Care Med 1997;23:58-64.
17. Wright PE, Carmichael LC, Bernard GR. Effect of broncho-dilators on lung mechanics in the acute respiratory distress syndrome (ARDS). Chest 1994;106:1517-23.
18. Pesenti A, Pelosi P, Rossi N, Aprigliano M, Brazzi L, Fumagalli R. Respiratory mechanics and bronchodilator responsiveness in patients with the adult respiratory distress syndrome. Crit Care Med 1993;21:78-83.
19. Robison GA, Butcher RW, Sutherland EW. Adenyl cyclase as an adrenergic receptor. Ann N YAcad Sci 1967;319:703-23.
20. Onaran HO, Costa T, Rodbard D. Subunits of guanine nucleotide-binding proteins and regulation of spontaneous receptor activity: thermodynamic model for the interaction between receptors and guanine nucleotide-binding protein subunits. Mol Pharmacol 1993;43:245-56.
21. Costa T, Ogino Y, Munson PJ, Onaran HO, Rodbard D. Drug efficacy at guanine nucleotide-binding regulatory protein-linked receptors: thermodynamic interpretation of negative antagonism and of receptor activity in the absence of ligand. Mol Pharmacol 1992;41:549-60.
22. van der Poll T, Coyole SM, Barbosa K, Braxton CC, Lowry SF. Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin 10 production during human endotoxemia. J Clin Invest 1996;97:713-9.
23. Zhang H, Kim YK, Govindarajan A, et al. Effect of adrenoreceptors on endotoxin-induced cytokines and lipid peroxidation in lung ex-plants. Am J Respir Crit Care Med 1999;160:1703-10.
24. Bissonnette EY, Befus AD. Anti-inflammatory effect of beta 2-agonists: inhibition of TNF-alpha release from human mast cells. J Allergy Clin Immunol 1997;100(6 pt 1):825-31.
25. 2-adrenergic agonists stimulate maximal cyclic adenosine monophosphate-dependent airspace fluid clearance and decrease pulmonary edema in experimental acid-induced lung injury. Crit Care Med 2004; 32:1470-6.
26. Sakuma T, Folkesson HG, Suzuki S, Okaniwa G, Fujimura S, Matthay MA. Beta-adrenergic agonist stimulated alveolar fluid clearance in ex vivo human and rat lungs. Am J Respir Crit Care Med 1997;155:506-12.
27. Ware LB, Matthay MA. Alveolar fluid clearance is impaired in the majority of patients with acute lung injury and the acute respiratory distress syndrome. Am J Respir Crit Care Med 2001;163:1376-83.
28. Matthay MA, Wiener-Kronish JP. Intact epithelial barrier function is critical for the resolution of alveolar edema in humans. Am Rev Respir Dis 1990;142:1250-7.
29. Matthay MA, Folkesson HG, Clerici C. Lung epithelial fluid transport and the resolution of pulmonary edema. Physiol Rev 2002;82:569-600.
30. Perkins GD, Gao F, Thickett DR. In vivo and in vitro effects of salbutamol upon alveolar epithelial repair in acute lung injury. Thorax 2008;63:215-20.
31. Perkins GD, McAuley DF, Thickett DR, Gao F. The β-agonist lung injury trial (BALTI): a randomized placebo-controlled clinical trial. Am J Respir Crit Care Med 2006; 173:281-7.
32. Manocha S, Gordon AC, Salehifar E, et al. Inhaled beta-2 agonist salbutamol and acute lung injury: an association with improvement in acute lung injury. Crit Care 2006;10:R12.
33. Sartori C, Allemann Y, Duplain H, et al. Salmeterol for the prevention of high-altitude pulmonary edema. N Engl J Med 2002;346:1631-6.
34. Palmieri T, Enkhbaatar P, Bayliss R, et al. Continuous nebulized albuterol attenuates acute lung injury in an ovine model of combined burn and smoke inhalation. Crit Care Med 2006;34:1719-24.